XML 61 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Stockholders' Equity (USD $)
Total
Common Stock [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Noncontrolling Interests [Member]
Balance at Dec. 31, 2009 $ 55,969,000 $ 32,000 $ 0 $ 173,672,000 $ 0 $ (120,242,000) $ 2,507,000
Common stock, shares outstanding at Dec. 31, 2009   31,912,066          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income attributable to Acacia Research Corporation 34,051,000         34,051,000  
Stock options exercised, shares   2,852,002          
Stock options exercised, value 15,068,000 3,000   15,065,000      
Stock issued during period, shares, share-based compensation, net of forfeitures   1,265,000          
Compensation expense related to stock options and restricted stock awards 7,121,000 1,000   7,120,000      
Excess tax benefits from stock-based compensation 1,302,000     1,302,000      
Net income (loss) attributable to noncontrolling interest 2,965,000           2,965,000
Contributions from noncontrolling interests in operating subsidiary, net 2,317,000           2,317,000
Distributions to noncontrolling interests in operating subsidiary (4,807,000)           (4,807,000)
Adjustments to Additional Paid in Capital, Other (133,000)     (133,000)      
Unrealized gain on foreign currency translation 0            
Unrealized gain (loss) on short-term investments 0            
Balance at Dec. 31, 2010 113,853,000 36,000 0 197,026,000 0 (86,191,000) 2,982,000
Common stock, shares outstanding at Dec. 31, 2010   36,029,068          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income attributable to Acacia Research Corporation 21,106,000         21,106,000  
Sale of common stock, shares   5,750,000          
Sale of common stock, value   6,000   175,223,000      
Proceeds from Issuance or Sale of Equity 175,229,000            
Stock options exercised, shares   87,068          
Stock options exercised, value 411,000     411,000      
Stock issued during period, shares, share-based compensation, net of forfeitures   1,061,865          
Compensation expense related to stock options and restricted stock awards 13,579,000 1,000   13,578,000      
Excess tax benefits from stock-based compensation 583,000     583,000      
Net income (loss) attributable to noncontrolling interest 539,000           539,000
Contributions from noncontrolling interests in operating subsidiary, net 1,539,000           1,539,000
Distributions to noncontrolling interests in operating subsidiary (2,897,000)           (2,897,000)
Unrealized gain on foreign currency translation 0            
Unrealized gain (loss) on short-term investments (1,830,000)            
Balance at Dec. 31, 2011 322,112,000 43,000 0 386,821,000 (1,830,000) (65,085,000) 2,163,000
Common stock, shares outstanding at Dec. 31, 2011 42,928,001 42,928,001          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income attributable to Acacia Research Corporation 59,453,000            
Sale of common stock, shares   6,122,449          
Sale of common stock, value 218,961,000 6,000   218,955,000      
Treasury stock, shares acquired 1,129,408 (1,129,408)          
Treasury stock, cost of shares acquired (26,732,000)   (26,731,000)        
Stock options exercised, shares 71,000 71,272          
Stock options exercised, value 340,000     340,000      
Stock issued during period, shares, share-based compensation, net of forfeitures   1,168,530          
Compensation expense related to stock options and restricted stock awards 25,657,000 1,000   25,656,000      
Excess tax benefits from stock-based compensation 13,210,000     13,210,000      
Net income (loss) attributable to noncontrolling interest (164,000)           (164,000)
Contributions from noncontrolling interests in operating subsidiary, net 5,793,000           5,793,000
Distributions to noncontrolling interests in operating subsidiary (816,000)           (816,000)
Unrealized gain on foreign currency translation 7,000       7,000    
Unrealized gain (loss) on short-term investments 657,000       657,000    
Balance at Dec. 31, 2012 $ 618,478,000 $ 49,000 $ (26,731,000) $ 644,982,000 $ (1,166,000) $ (5,632,000) $ 6,976,000
Common stock, shares outstanding at Dec. 31, 2012 49,160,844 49,160,844